KoreaMed

Kim JD, Lee WY

KMID: 2536952
Cardiovasc Prev Pharmacother.
2020 Jul;2(3):63-76.
doi: 10.36011/cpp.2020.2.e10

The number of patients with type 2 diabetes (T2D) is increasing worldwide and that in Korea, particularly, has shown an exponential increase with a rise in the older population. The...

Cite

CITED: export Copy Format; Close

SHARE: Close

2 Competing Risk Model in Survival Analysis

Jeon Y, Lee WK

KMID: 2536953
Cardiovasc Prev Pharmacother.
2020 Jul;2(3):77-84.
doi: 10.36011/cpp.2020.2.e11

Survival analysis is primarily used to identify the time-to-event for events of interest. However, there subjects may undergo several outcomes; competing risks occur when other events may affect the incidence...

Cite

CITED: export Copy Format; Close

SHARE: Close

3 Causal Claims in Health Sciences and Medicine: a Difference-in-Differences Method

Kim KN

KMID: 2536955
Cardiovasc Prev Pharmacother.
2020 Jul;2(3):99-102.
doi: 10.36011/cpp.2020.2.e13

The difference-in-differences (DID) method is a useful tool to make causal claims using observational data. The key idea is to compare the difference between exposure and control groups before and...

Cite

CITED: export Copy Format; Close

SHARE: Close

4 Pragmatic Clinical Trials for Real-World Evidence: Concept and Implementation

Jeong NY, Kim SH, Lim E, Choi NK

KMID: 2536954
Cardiovasc Prev Pharmacother.
2020 Jul;2(3):85-98.
doi: 10.36011/cpp.2020.2.e12

The importance of real-world evidence (RWE) has been highlighted in recent years, and the limitations of the classical randomized controlled trials, also known as explanatory clinical trials (ECTs), have been...

Cite